-
Galectin (GALT) Posts Q1 Loss of 22c/Share
-
Galectin Therapeutics Reports First Quarter 2013 Financial Results
-
Galectin (GALT) Posts Q3 Loss of 19c/Share
-
Galectin (GALT) Reports Q2 Loss of $0.19
